Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: J Hepatol. 2015 Jul 15;63(5):1103–1110. doi: 10.1016/j.jhep.2015.06.035

Table 5.

African American participants from ALIVE, UHS and WIHS with chronic or cleared HCV infection, genotype proportions for IFNL4-ΔG/TT (rs368234815) and IFNL3 rs4803217 variants, and corresponding Mantel-Haenszel (M-H) odds ratios, 95% confidence intervals (95% CI) and p-values for each association.

Variant IFNL4-ΔG/TT rs4803217

Genotype ΔG/ΔG ΔG/TT TT/TT T/T T/G G/G
ALIVE Chronic (%) [N= 534] 43.3 [231] 45.9 [245] 10.9 [58] 40.6 [217] 44.8 [239] 14.6 [78]
Cleared (%) [N= 59] 23.7 [14] 39.0 [23] 37.3 [22] 23.7 [14] 30.5 [18] 45.8 [27]
Odds ratio Ref. 1.55 6.26 Ref. 1.17 5.37
95% CI - 0.78–3.08 3.02–12.98 - 0.57–2.45 2.68–10.76
p-value 0.21 8.3×10−7 0.67 2.2×10−6
UHS Chronic (%) [N=276] 36.6 [101] 50.0 [138] 13.4 [37] 32.2 [89] 52.5 [145] 15.2 [42]
Cleared (%) [N=87] 24.1 [21] 47.1 [41] 28.7 [25] 25.3 [22] 47.1 [41] 27.6 [24]
Odds ratio Ref. 1.43 3.25 Ref. 1.14 2.31
95% CI 0.80–2.57 1.63–6.49 0.64–2.05 1.17–4.59
p-value 0.23 8.4×10−4 0.65 0.02
WIHS Chronic (%) [N=437] 41.2 [180] 46.5 [203] 12.4 [54] 36.2 [158] 46.5 [203] 17.4 [76]
Cleared (%) [N=82] 31.7 [26] 32.9 [27] 35.4 [29] 26.8 [22] 37.8 [31] 35.4 [29]
Odds ratio Ref. 0.92 3.72 Ref. 1.10 2.74
95% CI - 0.52–1.65 2.02–6.85 - 0.61–1.97 1.48–5.08
p-value 0.78 2.0×10−5 0.76 0.001
TOTAL Chronic (%) [N=1,247]
Cleared (%) [N=228]
M-H Odds ratio Ref. 1.25 4.14 Ref. 1.15 3.22
95% CI 0.88–1.77 2.81–6.11 0.80–1.64 2.20–4.72
p-value 0.21 7.2×10−13 0.45 2.0×10−9